The Use of Liraglutide in Brain Death

Status Completed

Clinical Trial Summary

There is evidence of the association of brain death and inflammation, affecting outcomes of transplanted organs, but in a way not fully understood. Observational studies suggest that the use of target-guided therapies has a beneficial effect in reducing the rate of donor loss due to cardiac arrest and increasing the rate of donor-picked organs, which will be tested through the randomized clinical trial. However, no study so far has directly tested the effect of drugs with anti-inflammatory and anti-apoptotic properties administered to the donor in encephalic death in reducing inflammation of organs to be transplanted. This study aims to evaluate the use of liraglutide in patients with brain death in relation to their ability to attenuate the inflammation induced by encephalic death by means of a randomized clinical trial.

Clinical Trial Description

The intervention group will be composed of individuals deceased in brain dead, after the conclusion of the brain dead protocol by the teams responsible for the Intensive care and will receive liraglutide. The control group will be composed of the same population of individuals who died in brain dead of the intervention group, but will receive a placebo. ;

Study Design

Related Conditions & MeSH terms

Clinical Trial Details

NCT number	NCT03672812
Study type	Interventional
Source	Hospital de Clinicas de Porto Alegre
Contact
Status	Completed
Phase	Phase 3
Start date	September 1, 2018
Completion date	February 10, 2022

View Details

See also
Status	Clinical Trial	Phase
Recruiting	`NCT03765814` - The Anticipated Organ Donation Approach
Completed	`NCT02581111` - Naloxone for Optimizing Hypoxemia Of Lung Donors	Phase 2/Phase 3
Completed	`NCT00808691` - Microcirculation and Oxidative Stress in Critical Ill Patients in Surgical Intensive Care Unit	N/A
Completed	`NCT00998972` - N-acetyl-cysteine (NAC) and Kidney Graft Function	Phase 3
Completed	`NCT04528797` - Thyroid and Adrenocortical Hormone Replacement in Organ Donors	N/A
Completed	`NCT04303624` - Understanding Family Refusal
Completed	`NCT03098706` - Therapeutic Hypothermia in "Expanded Criteria" Brain-dead Donors and Kidney-graft Function	N/A
Not yet recruiting	`NCT04623294` - Online Noninvasive Assessment of Human Brain Death and Deep Coma by Near-infrared Spectroscopy
Recruiting	`NCT02102945` - Special Imaging Technique to Aid in the Diagnosis of Patients in Coma After Cardiac Arrest	N/A
Completed	`NCT02483273` - Alterations of Conjunctival Microcirculation in Brain Dead Patients	N/A
Terminated	`NCT00675272` - Organ Donation and Hydrocortisone Treatment	N/A
Completed	`NCT03262896` - Neurophysiological Examination in Patients With Brain Death
Not yet recruiting	`NCT06359119` - Implementation of Apnoea Test for Patients With Suspected Brain Death
Recruiting	`NCT05202886` - "LiverColor": Machine Learning in Liver Photographs	N/A
Completed	`NCT03281993` - Apnea Tests as the Methods of Brain Death Diagnosis.	N/A
Completed	`NCT03179020` - Donation Network to Optimize Organ Recovery Study	N/A
Completed	`NCT05070182` - Resting Energy Needs in Brain Dead Patients (reSting EneRgy nEeds iN brAin DEad Patients)
Terminated	`NCT03439995` - Goal of Open Lung Ventilation in Donors	N/A
Completed	`NCT02525510` - Deceased Organ Donor Interventions to Protect Kidney Graft Function	N/A
Completed	`NCT02742857` - Non-randomized, Open-labeled, Interventional, Single Group, Proof of Concept Study With Multi-modality Approach in Cases of Brain Death Due to Traumatic Brain Injury Having Diffuse Axonal Injury	Phase 1